Sclerosis Systemic

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-12-20
Clinical Trial Update: Effects of FT011 in Systemic Sclerosis [Phase 2]
Phase 2 trial update on FT011 for systemic sclerosis (scleroderma) has been completed with results posted in 2023.